Showing results (951-960 of 986) with videos related to

Sort By:
Pageof 99
Journal of Medicinal Chemistry|August 19, 2008
Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptorJános T Kodra, Anker Steen Jørgensen, Birgitte Andersen, et al.
European Journal of Medicinal Chemistry|February 21, 2020
Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activityLionel Froux, Ahmad Elbahnsi, Benjamin Boucherle, et al.
Environmental Health Perspectives|January 13, 2010
Persistent organic pollutant exposure leads to insulin resistance syndromeJérôme Ruzzin, Rasmus Petersen, Emmanuelle Meugnier, et al.
Obesity (Silver Spring, Md.)|December 7, 2015
One-year outcomes of an intense workplace cardio-metabolic risk reduction program among high-risk employees: The My Unlimited PotentialMaribeth Rouseff, Ehimen C Aneni, Henry Guzman, et al.
Age and Ageing|March 23, 2026
Best practice guidelines for the diagnosis, evaluation, and management of cognitive disorders in Parkinson's diseaseDana Pourzinal, Deborah Brooks, Deepa Sriram, et al.
Movement Disorders Clinical Practice|August 20, 2025
The Management of Parkinson's Disease Before, during and after Pregnancy-an MDS Scientific Issues Committee ReviewAlexander C Lehn, Jee-Young Lee, Giorgia Sciacca, et al.
Journal of Parkinson'S Disease|October 21, 2015
Tracking Parkinson's: Study Design and Baseline Patient DataNaveed Malek, Diane M A Swallow, Katherine A Grosset, et al.
Journal of Dairy Science|October 15, 2018
Assessment of selenium bioaccumulation in lactic acid bacteriaAna Paula Mörschbächer, Anja Dullius, Carlos Henrique Dullius, et al.
Population Health Management|January 14, 2016
The Effectiveness of a Worksite Lifestyle Intervention Program on High-Risk Individuals as Potential Candidates for Bariatric Surgery: My Unlimited Potential (MyUP)Chukwuemeka U Osondu, Ehimen C Aneni, Sameer Shaharyar, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 26, 2026
Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical TrialGlenn J Hanna, Olga Y Zamulko, Punita Grover, et al.
Pageof 99